| Identification | Back Directory | [Name]
Benzoic acid, 2-hydroxy-, 2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide | [CAS]
70169-39-0 | [Synonyms]
WAY-358024
2-hydroxy-N'-(2-oxo-2,3-dihydro-1H-indol-3-ylidene)benzohydrazide
Benzoic acid, 2-hydroxy-, 2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide | [Molecular Formula]
C15H11N3O3 | [MOL File]
70169-39-0.mol | [Molecular Weight]
281.27 |
| Hazard Information | Back Directory | [Uses]
GSK-3β inhibitor 26 (Compound D14) is a GSK-3β inhibitor with an IC50 of 18.23 μM. GSK-3β inhibitor 26 can be used in the research of cancer, inflammation and neurodegenerative diseases[1]. | [IC 50]
GSK-3β: 18.23 μM (IC50) | [References]
[1] Dou X, et al. Discovery of new GSK-3β inhibitors through structure-based virtual screening. Bioorg Med Chem Lett. 2018 Jan 15;28(2):160-166. DOI:10.1016/j.bmcl.2017.11.036 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
www.biorbyt.com |
|